Log in

Evonile Pharma

EVONILE· NSE· Healthcare
₹1,596.00
+₹27.90 (+1.78%) · 1Das of 12 Nov 2026, 20:31 IST

Evonile Pharma (EVONILE) last traded at ₹1,596.00 on NSE as of 12 Nov 2026, 20:31 IST, up 1.78% (+₹27.90) on the day. The stock is 1.8% below its 52-week high of ₹1,625.00 and 18.5% above its 52-week low of ₹1,346.50. Market cap ₹3,941 crore. Sector: Healthcare.

Day range₹1,555.00 – ₹1,625.00
52-week range₹1,346.50 – ₹1,625.00
Volume43,094
Market cap₹3,941 crore
P/E · P/B— · —trailing
EPS—
Returns1W+10.50%1M—3M—6M—YTD—1Y—3Y—5Y—

Fundamentals

No reported fundamentals for this instrument.

Trailing figures from the last reported year

Technicals

RSI (14)—
20-day average· ——
50-day average· ——
200-day average· ——
ATR (14)—
20-session change—
Volatility· 30 sessions, annualised—
From completed sessions; the RSI alone steps with the live price.

Sector today

Healthcare
Move today+0.04%
Breadth53% of stocks up
RotationImproving
Against the NIFTY 50 · breadth is the share of the sector's stocks up today

Latest news

All EVONILE news ↗

No publisher article about Evonile Pharma in the last 7 days.

Upcoming events

Event calendar ↗

No upcoming company event is listed for Evonile Pharma.

Frequently asked

What is the Evonile Pharma share price today?

Evonile Pharma (EVONILE) last traded at ₹1,596.00 on NSE as of 12 Nov 2026, 20:31 IST, up 1.78% (+₹27.90) on the day.

What is the 52-week high and low of EVONILE?

The 52-week range of Evonile Pharma is ₹1,346.50 to ₹1,625.00; the last price is 1.8% below the high.

What is the market capitalisation of Evonile Pharma?

₹3,941 crore at the last price (NSE's issued shares × price).

What is the P/E ratio of Evonile Pharma?

A trailing P/E for Evonile Pharma is not available right now.

Which sector is Evonile Pharma in, and how is the sector doing today?

Healthcare. The sector is up 0.04% today, with 53% of its stocks up (Improving against the NIFTY 50).

What is the next scheduled event for Evonile Pharma?

No upcoming company event is listed for Evonile Pharma.

Data as of 12 Nov 2026, 20:31 IST · Research, not investment advice.